Medicines Moleculin Receives Approval from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for Protocol Amendment to Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19 By Helena Musk / May 11, 2022
Weight Loss Programs A cluster randomized trial to evaluate “Lifestyle Africa” in South Africa By Helena Musk / April 22, 2022
